{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:22:47Z","timestamp":1784780567427,"version":"3.55.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Care of critically ill children includes sedation but current therapies are suboptimal. To describe dexmedetomidine use in children supported on mechanical ventilation for acute respiratory failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Secondary analysis of data from the Randomized Evaluation of Sedation Titration for Respiratory Failure clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Thirty-one PICUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Data from 2,449 children; 2 weeks to 17 years old.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Sedation practices were unrestrained in the usual care arm. Patients were categorized as receiving dexmedetomidine as a primary sedative, secondary sedative, periextubation agent, or never prescribed. Dexmedetomidine exposure and sedation and clinical profiles are described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Of 1,224 usual care patients, 596 (49%) received dexmedetomidine. Dexmedetomidine as a primary sedative patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 138; 11%) were less critically ill (Pediatric Risk of Mortality III-12 score median, 6 [interquartile range, 3\u201311]) and when compared with all other cohorts, experienced more episodic agitation. In the intervention group, time in sedation target improved from 28% to 50% within 1 day of initiating dexmedetomidine as a primary sedative. Dexmedetomidine as a secondary sedative usual care patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 280; 23%) included more children with severe pediatric acute respiratory distress syndrome or organ failure. Dexmedetomidine as a secondary sedative patients experienced more inadequate pain (22% vs 11%) and sedation (31% vs 16%) events. Dexmedetomidine as a periextubation agent patients (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 178; 15%) were those known to not tolerate an awake, intubated state and experienced a shorter ventilator weaning process (2.1 vs 2.3 d).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our data support the use of dexmedetomidine as a primary agent in low criticality patients offering the benefit of rapid achievement of targeted sedation levels. Dexmedetomidine as a secondary agent does not appear to add benefit. The use of dexmedetomidine to facilitate extubation in children intolerant of an awake, intubated state may abbreviate ventilator weaning. These data support a broader armamentarium of pediatric critical care sedation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/pcc.0000000000000941","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T13:35:55Z","timestamp":1474464955000},"page":"1131-1141","source":"Crossref","is-referenced-by-count":66,"title":["Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure*"],"prefix":"10.1097","volume":"17","author":[{"given":"Mary Jo C.","family":"Grant","sequence":"first","affiliation":[{"name":"Department of Pediatric Critical Care, Primary Children\u2019s Hospital, Salt Lake City, UT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Schneider","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Cohen Children\u2019s Medical Center, Hofstra-Northwell School of Medicine, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Asaro","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Dodson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, UC Davis Medical Center, Sacramento, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari L.","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Pediatric Critical Care, University of Maryland Medical Center, Baltimore, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison S.","family":"Cowl","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Connecticut Children\u2019s Medical Center, Hartford, CT."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Munkwitz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Critical Care Medicine, Department of Pediatric Critical Care, Phoenix Children\u2019s Hospital, University of Arizona College of Medicine, Phoenix, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wypij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A. Q.","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1460-9592.2006.02180.x","article-title":"Current United Kingdom sedation practice in pediatric intensive care.","volume":"17","author":"Jenkins","year":"2007","journal-title":"Paediatr Anaesth"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/CCM.0000000000000326","article-title":"Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: A wake-up call for the pediatric critical care community.","volume":"42","author":"Kudchadkar","year":"2014","journal-title":"Crit Care Med"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.PCC.0000144710.13710.2E","article-title":"Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: Survey of fellowship training programs.","volume":"5","author":"Twite","year":"2004","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/PCC.0b013e3181a3191f","article-title":"The use of dexmedetomidine in critically ill children.","volume":"10","author":"Czaja","year":"2009","journal-title":"Pediatr Crit Care Med"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1542\/peds.2011-3822","article-title":"Long-term differences in language and cognitive function after childhood exposure to anesthesia.","volume":"130","author":"Ing","year":"2012","journal-title":"Pediatrics"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1213\/ANE.0b013e3182147f42","article-title":"Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort.","volume":"113","author":"DiMaggio","year":"2011","journal-title":"Anesth Analg"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2009.56","article-title":"Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial.","volume":"301","author":"Riker","year":"2009","journal-title":"JAMA"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","article-title":"Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial.","volume":"298","author":"Pandharipande","year":"2007","journal-title":"JAMA"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","article-title":"Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: Two randomized controlled trials.","volume":"307","author":"Jakob","year":"2012","journal-title":"JAMA"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2131\/jts.39.251","article-title":"Neurotoxic effects of dexmedetomidine in fetal cynomolgus monkey brains.","volume":"39","author":"Koo","year":"2014","journal-title":"J Toxicol Sci"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000542-199308000-00016","article-title":"Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia.","volume":"79","author":"Maier","year":"1993","journal-title":"Anesthesiology"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000542-199708000-00025","article-title":"Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia.","volume":"87","author":"Kuhmonen","year":"1997","journal-title":"Anesthesiology"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1399-6576.2009.02177.x","article-title":"Dexmedetomidine provides cortical neuroprotection: Impact on anaesthetic-induced neuroapoptosis in the rat developing brain.","volume":"54","author":"Sanders","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S1047951109003515","article-title":"Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.","volume":"19","author":"Bejian","year":"2009","journal-title":"Cardiol Young"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00007611-200405000-00007","article-title":"Sedation during mechanical ventilation in infants and children: Dexmedetomidine versus midazolam.","volume":"97","author":"Tobias","year":"2004","journal-title":"South Med J"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/PCC.0b013e318253c7f1","article-title":"Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease.","volume":"13","author":"Gupta","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/0218492315585644","article-title":"Dexmedetomidine in combination with midazolam after pediatric cardiac surgery.","volume":"23","author":"Hasegawa","year":"2015","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/PCC.0000000000000200","article-title":"Long-term dexmedetomidine use and safety profile among critically ill children and neonates.","volume":"15","author":"Whalen","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2014.18399","article-title":"Protocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: A randomized clinical trial.","volume":"313","author":"Curley","year":"2015","journal-title":"JAMA"},{"key":"R20-20230823","first-page":"293","article-title":"The FLACC: A behavioral scale for scoring postoperative pain in young children.","volume":"23","author":"Merkel","year":"1997","journal-title":"Pediatr Nurs"},{"key":"R21-20230823","first-page":"9","article-title":"Pain in children: Comparison of assessment scales.","volume":"14","author":"Wong","year":"1988","journal-title":"Pediatr Nurs"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0882-5963(03)00090-3","article-title":"Pain assessment in nonverbal children with severe cognitive impairments: The Individualized Numeric Rating Scale (INRS).","volume":"18","author":"Solodiuk","year":"2003","journal-title":"J Pediatr Nurs"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.PCC.0000200955.40962.38","article-title":"State Behavioral Scale: A sedation assessment instrument for infants and young children supported on mechanical ventilation.","volume":"7","author":"Curley","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The Withdrawal Assessment Tool-1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-3476(05)82544-2","article-title":"Assessing the outcome of pediatric intensive care.","volume":"121","author":"Fiser","year":"1992","journal-title":"J Pediatr"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00003246-199605000-00004","article-title":"PRISM III: An updated Pediatric Risk of Mortality score.","volume":"24","author":"Pollack","year":"1996","journal-title":"Crit Care Med"},{"issue":"5 Suppl 1","key":"R27-20230823","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/PCC.0000000000000432","article-title":"Pediatric acute respiratory distress syndrome: Definition, incidence, and epidemiology: Proceedings from the Pediatric Acute Lung Injury Consensus Conference.","volume":"16","author":"Khemani","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/CCM.0b013e31823c8ae3","article-title":"Prospective evaluation of sedation-related adverse events in pediatric patients ventilated for acute respiratory failure.","volume":"40","author":"Grant","year":"2012","journal-title":"Crit Care Med"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.0006-341X.1999.00137.x","article-title":"Estimating intraclass correlation for binary data.","volume":"55","author":"Ridout","year":"1999","journal-title":"Biometrics"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1002\/sim.1330","article-title":"A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.","volume":"21","author":"Ukoumunne","year":"2002","journal-title":"Stat Med"},{"key":"R31-20230823","first-page":"21","article-title":"Safety and effectiveness of dexmedetomidine in the pediatric intensive care unit (SAD-PICU).","volume":"66","author":"Carney","year":"2013","journal-title":"Can J Hosp Pharm"},{"key":"R32-20230823","first-page":"45","article-title":"Effects of clonidine on withdrawal from long-term dexmedetomidine in the pediatric patient.","volume":"20","author":"Lardieri","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/0960327112454896","article-title":"Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature.","volume":"32","author":"Kukoyi","year":"2013","journal-title":"Hum Exp Toxicol"},{"key":"R34-20230823","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.braindev.2016.02.003","article-title":"Potential risk factors for dexmedetomidine withdrawal seizures in infants after surgery for congenital heart disease.","volume":"38","author":"Takahashi","year":"2016","journal-title":"Brain Dev"},{"key":"R35-20230823","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/PCC.0000000000000208","article-title":"Long-term dexmedetomidine use for pediatric critical care sedation: No need to sleep on it.","volume":"15","author":"Berkenbosch","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R36-20230823","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.PCC.0000200967.76996.07","article-title":"Use of dexmedetomidine in children after cardiac and thoracic surgery.","volume":"7","author":"Chrysostomou","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R37-20230823","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/PCC.0b013e3181b062d7","article-title":"Dexmedetomidine sedation in children after cardiac surgery.","volume":"11","author":"Hosokawa","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R38-20230823","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/PCC.0b013e31828a8800","article-title":"A dose-response study of dexmedetomidine administered as the primary sedative in infants following open heart surgery.","volume":"14","author":"Su","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R39-20230823","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00134-011-2441-8","article-title":"Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.","volume":"38","author":"Burbano","year":"2012","journal-title":"Intensive Care Med"},{"key":"R40-20230823","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1592\/phco.28.1.51","article-title":"Use of dexmedetomidine in the pediatric intensive care unit.","volume":"28","author":"Buck","year":"2008","journal-title":"Pharmacotherapy"},{"key":"R41-20230823","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PCC.0b013e3181a66131","article-title":"Withdrawal from multiple sedative agent therapy in an infant: Is dexmedetomidine the cause or the cure?","volume":"11","author":"Darnell","year":"2010","journal-title":"Pediatr Crit Care Med"},{"key":"R42-20230823","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1460-9592.2006.02008.x","article-title":"Prolonged use of dexmedetomidine in an infant with respiratory failure following living donor liver transplantation.","volume":"16","author":"Enomoto","year":"2006","journal-title":"Paediatr Anaesth"},{"key":"R43-20230823","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00246-005-0683-3","article-title":"Use of dexmedetomidine in a pediatric heart transplant patient.","volume":"26","author":"Chrysostomou","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"R44-20230823","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1097\/01.CCM.0000178183.21883.23","article-title":"The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children.","volume":"33","author":"Finkel","year":"2005","journal-title":"Crit Care Med"},{"key":"R45-20230823","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1213\/01.ANE.0000113547.34160.A5","article-title":"The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant.","volume":"98","author":"Finkel","year":"2004","journal-title":"Anesth Analg"},{"key":"R46-20230823","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2710.2008.00883.x","article-title":"Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.","volume":"33","author":"Arpino","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"R47-20230823","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00000542-200302000-00024","article-title":"The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects.","volume":"98","author":"Nelson","year":"2003","journal-title":"Anesthesiology"},{"key":"R48-20230823","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1460-9592.2009.03160.x","article-title":"Effects of dexmedetomidine sedation on the EEG in children.","volume":"19","author":"Mason","year":"2009","journal-title":"Paediatr Anaesth"},{"key":"R49-20230823","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-6576.2007.01537.x","article-title":"Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep.","volume":"52","author":"Huupponen","year":"2008","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201612000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T19:09:44Z","timestamp":1692817784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201612000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000000941","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726765370.793527374","asserted-by":"object"}]},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}